| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037115 |
| Receipt No. | R000042286 |
| Scientific Title | Assessment on no observed adverse effect level of the test food (HBF2019-01) for loose stools |
| Date of disclosure of the study information | 2019/06/24 |
| Last modified on | 2020/01/31 (Ver. 5) |
| Basic information | ||
| Public title | Assessment on no observed adverse effect level of the test food (HBF2019-01) for loose stools | |
| Acronym | Assessment on no observed adverse effect level of the test food for loose stools | |
| Scientific Title | Assessment on no observed adverse effect level of the test food (HBF2019-01) for loose stools | |
| Scientific Title:Acronym | Assessment on no observed adverse effect level of the test food for loose stools | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To estimate no observed adverse effect level of the test food for loose stools |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Stool form |
| Key secondary outcomes | Abdominal symptoms |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Stepwise feeding of test food | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy adults who had at least 3 defecations per week
2) Employees at the Hayashibara CO., LTD. 3) Subjects who agree to sign the informed consent for participation in the study 4) Subjects who may cause loose stools besides feeding of the test food |
|||
| Key exclusion criteria | 1) Underage
2) Women who are pregnant or may be pregnant 3) Subjects who may affect the result of the study due to the medications 4) Subjects who are judged to have loose stools or constipation on a daily basis 5) Subjects who cannot attend the designated time and place 6) Subjects who judged as unsuitable for this study by the principal physician investigator |
|||
| Target sample size | 15 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hayashibara Co., Ltd. | ||||||
| Division name | Development Unit, R&D Division | ||||||
| Zip code | 702-8006 | ||||||
| Address | 675-1, Fujisaki, Naka-ku, Okayama, Japan | ||||||
| TEL | 086-276-3141 | ||||||
| tsuyoshi.sadakiyo@hb.nagase.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hayashibara Co., Ltd. | ||||||
| Division name | Development Unit, R&D Division | ||||||
| Zip code | 702-8006 | ||||||
| Address | 675-1, Fujisaki, Naka-ku, Okayama, Japan | ||||||
| TEL | 086-276-3141 | ||||||
| Homepage URL | |||||||
| tsuyoshi.sadakiyo@hb.nagase.co.jp | |||||||
| Sponsor | |
| Institute | Hayashibara Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Committee of Hayashibara Co., Ltd. |
| Address | 675-1, Fujisaki, Naka-ku, Okayama, Japan |
| Tel | 086-276-3141 |
| HB96301@hb.nagase.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 株式会社林原(岡山県) / Hayashibara Co., Ltd. (Okayama) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 20 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042286 |